ES530759A0 - Un procedimiento para preparar conjugados de galactosil-insulina - Google Patents

Un procedimiento para preparar conjugados de galactosil-insulina

Info

Publication number
ES530759A0
ES530759A0 ES530759A ES530759A ES530759A0 ES 530759 A0 ES530759 A0 ES 530759A0 ES 530759 A ES530759 A ES 530759A ES 530759 A ES530759 A ES 530759A ES 530759 A0 ES530759 A0 ES 530759A0
Authority
ES
Spain
Prior art keywords
galactosil
preparing
procedure
insulin conjugates
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530759A
Other languages
English (en)
Other versions
ES8606407A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of ES530759A0 publication Critical patent/ES530759A0/es
Publication of ES8606407A1 publication Critical patent/ES8606407A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02—Monosaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES530759A 1983-03-21 1984-03-20 Un procedimiento para preparar conjugados de galactosil-insulina Expired ES8606407A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47755583A 1983-03-21 1983-03-21

Publications (2)

Publication Number Publication Date
ES530759A0 true ES530759A0 (es) 1986-04-01
ES8606407A1 ES8606407A1 (es) 1986-04-01

Family

ID=23896415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530759A Expired ES8606407A1 (es) 1983-03-21 1984-03-20 Un procedimiento para preparar conjugados de galactosil-insulina

Country Status (6)

Country Link
EP (1) EP0119650A3 (es)
JP (1) JPS6011426A (es)
AU (1) AU2589984A (es)
ES (1) ES8606407A1 (es)
PH (1) PH22300A (es)
ZA (1) ZA842051B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504099D0 (en) * 1985-02-18 1985-03-20 Wellcome Found Physiologically active substances
DK111489D0 (da) * 1989-03-08 1989-03-08 Novo Nordisk As Peptider
JPH11507942A (ja) * 1995-06-23 1999-07-13 オックスフォード グリコサイエンセス（ユーケー） リミテッド 治療用化合物
GB9626450D0 (en) * 1996-12-20 1997-02-05 Oxford Glycosciences Uk Ltd Therapeutic compounds
KR101635689B1 (ko) 2009-01-28 2016-07-01 스마트쎌스, 인크. 제어 약물 전달을 위한 접합체 기재 시스템
US8940690B2 (en) 2009-01-28 2015-01-27 National Institutes Of Health (Nih) Synthetic conjugates and uses thereof
JP2012516339A (ja) 2009-01-28 2012-07-19 スマートセルズ・インコーポレイテツド 外因的刺激型制御放出物質体およびその使用
EP2391646B1 (en) 2009-01-28 2016-08-10 Smartcells, Inc. Crystalline insulin-conjugates
WO2010107520A1 (en) 2009-03-20 2010-09-23 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
JP2012520879A (ja) 2009-03-20 2012-09-10 スマートセルズ・インコーポレイテツド 末端官能基化コンジュゲートおよびその用途
AU2011282988A1 (en) 2010-07-28 2013-01-31 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
AU2011282987A1 (en) 2010-07-28 2013-02-21 Smartcells, Inc. Recombinant lectins, binding-site modified lectins and uses thereof
EP2598170A4 (en) 2010-07-28 2016-07-06 Smartcells Inc MEDICAMENT-LIGAND CONJUGATES, THEIR SYNTHESIS AND CORRESPONDING INTERMEDIATES
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
WO2012021512A2 (en) 2010-08-10 2012-02-16 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
CA2890048C (en) 2012-12-03 2022-05-03 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
AU2014329567B2 (en) 2013-10-04 2019-07-25 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3909603A1 (en) 2014-02-21 2021-11-17 Ecole Polytechnique Fédérale de Lausanne (EPFL) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847890A (en) * 1971-11-01 1974-11-12 A Green Acidic monosaccharide-substituted proteins
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid

Also Published As

Publication number Publication date
ZA842051B (en) 1984-10-31
EP0119650A3 (en) 1987-09-30
JPS6011426A (ja) 1985-01-21
PH22300A (en) 1988-07-22
EP0119650A2 (en) 1984-09-26
AU2589984A (en) 1984-09-27
ES8606407A1 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
ES530759A0 (es) Un procedimiento para preparar conjugados de galactosil-insulina
ES554546A0 (es) Un procedimiento para preparar derivados de guanina
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES543192A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES532536A0 (es) Un procedimiento para preparar un derivado de carbostirilo
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES533873A0 (es) Un procedimiento para preparar profarmacos de alopurinol
ES537668A0 (es) Un procedimiento para preparar n-formil-3-fenoxi-1-azetidincarboxamidas
ES523195A0 (es) Un procedimiento para preparar alquil-glicosidos
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES523193A0 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona